Gallbladder adenosquamous carcinoma

Summary

Gallbladder adenosquamous carcinoma (MONDO:0006217) is a cancer. A subtype of adenosquamous carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gallbladder adenosquamous carcinoma
Mondo ID	MONDO:0006217
EFO	EFO:1000264
DOID	DOID:5627
NCIT	C7356
UMLS	C1333741
MedGen	232539
GARD	0024334
Anatomy (UBERON)	UBERON:0002110
Is cancer (heuristic)	yes

Also known as: adenosquamous carcinoma of gallbladder · adenosquamous carcinoma of the gallbladder · adenosquamous gallbladder carcinoma · gall bladder adenosquamous carcinoma · gallbladder adenosquamous cancer · gallbladder adenosquamous carcinoma · GBASC

Data availability: 1 cell line.

Disease family

This is a subtype of adenosquamous carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › squamous cell neoplasm › squamous cell carcinoma › adenosquamous carcinoma › gallbladder adenosquamous carcinoma

Related subtypes (14): adenosquamous breast carcinoma, esophageal adenosquamous carcinoma, thymic adenosquamous carcinoma, Bartholin gland adenosquamous carcinoma, endometrial adenosquamous carcinoma, adenosquamous prostate carcinoma, adenosquamous lung carcinoma, pancreatic adenosquamous carcinoma, gastric adenosquamous carcinoma, cervical adenosquamous carcinoma, colorectal adenosquamous carcinoma, salivary gland adenosquamous carcinoma, liver adenosquamous carcinoma, skin adenosquamous carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.